Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Blocking certain proteins on immune cells may help treat alopecia areata.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Age-related immune changes significantly affect disease development in other systems.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

Immunoadsorption successfully treated a man's resistant polymyositis.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Low-output laser irradiation can stimulate or inhibit biological processes depending on the dose.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.